Pasithea Therapeutics Corp. (KTTA)

Number of records: 27
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
06-Jun-23 10:00 PM
View: 
Steinman Lawrence
Director
Pasithea Therapeutics Corp. (KTTA) 02-Jun-23Private Purchase 30,000$0.43$12,930.002%
1.3M to 1.33M
28-Nov-22 4:00 PM
View: 
Steinman Lawrence
Director
Pasithea Therapeutics Corp. (KTTA) 28-Nov-22Grant 5,000$0.98$4,900.00< 1%
1.28M to 1.29M
28-Nov-22 4:00 PM
View: 
Marques Tiago
Chief Executive Officer
Director
Pasithea Therapeutics Corp. (KTTA) 25-Nov-22Grant 2,000$1.03$2,060.00< 1%
817.21K to 819.21K
28-Nov-22 4:00 PM
View: 
Marques Tiago
Chief Executive Officer
Director
Pasithea Therapeutics Corp. (KTTA) 23-Nov-22Grant 7,206$1.01$7,260.12< 1%
810.0K to 817.21K
22-Nov-22 4:10 PM
View: 
Steinman Lawrence
Director
Pasithea Therapeutics Corp. (KTTA) 22-Nov-22Grant 5,000$0.99$4,950.00< 1%
1.28M to 1.28M
17-Nov-22 4:34 PM
View: 
Dumesnil Simon
Director
Pasithea Therapeutics Corp. (KTTA) 17-Nov-22Grant 40,000$1.06$42,400.00400%
10.0K to 50.0K
17-Nov-22 4:34 PM
View: 
Dumesnil Simon
Director
Pasithea Therapeutics Corp. (KTTA) 15-Nov-22Grant 10,000$1.07$10,700.00100%
0 to 10.0K
26-Oct-22 5:35 PM
View: 
Steinman Lawrence
Director
Pasithea Therapeutics Corp. (KTTA) 26-Oct-22Grant 5,000$1.10$5,500.00< 1%
1.27M to 1.28M
21-Oct-22 5:05 PM
View: 
Marques Tiago
Chief Executive Officer
Director
Pasithea Therapeutics Corp. (KTTA) 21-Oct-22Grant 5,000$1.07$5,356.00< 1%
805.0K to 810.0K
17-Oct-22 6:11 PM
View: 
Steinman Lawrence
Director
Pasithea Therapeutics Corp. (KTTA) 17-Oct-22Grant 10,000$1.13$11,310.00< 1%
1.26M to 1.27M
19-Oct-22 5:29 PM
View: 
Delaney David
Pasithea Therapeutics Corp. (KTTA) 17-Oct-22Private Purchase 1,000$1.11$1,110.00< 1%
226.52K to 227.52K
30-Sep-22 4:36 PM
View: 
Shahinian Eric
Pasithea Therapeutics Corp. (KTTA) 29-Sep-22Purchase 6,710$1.16$7,756.76< 1%
1.78M to 1.79M
30-Sep-22 4:36 PM
View: 
Shahinian Eric
Pasithea Therapeutics Corp. (KTTA) 28-Sep-22Private Purchase 57,647$1.19$68,542.303%
1.72M to 1.78M
06-Sep-22 5:03 PM
View: 
Shahinian Eric
Pasithea Therapeutics Corp. (KTTA) 06-Sep-22Purchase 21,748$1.13$24,631.801%
1.7M to 1.72M
06-Sep-22 5:03 PM
View: 
Shahinian Eric
Pasithea Therapeutics Corp. (KTTA) 02-Sep-22Purchase 11,507$1.14$13,105.30< 1%
1.69M to 1.7M
06-Sep-22 5:03 PM
View: 
Shahinian Eric
Pasithea Therapeutics Corp. (KTTA) 01-Sep-22Private Purchase 55,646$1.13$62,629.603%
1.64M to 1.69M
31-Aug-22 4:32 PM
View: 
Shahinian Eric
Pasithea Therapeutics Corp. (KTTA) 30-Aug-22Purchase 17,828$1.15$20,452.301%
1.62M to 1.64M
31-Aug-22 4:32 PM
View: 
Shahinian Eric
Pasithea Therapeutics Corp. (KTTA) 29-Aug-22Private Purchase 5,000$1.17$5,840.50< 1%
1.61M to 1.62M
26-Aug-22 4:30 PM
View: 
Geller Avi
Pasithea Therapeutics Corp. (KTTA) 19-Aug-22Private Purchase 54,644$1.30$70,938.805%
1.03M to 1.09M
18-Aug-22 7:35 PM
View: 
Shahinian Eric
Pasithea Therapeutics Corp. (KTTA) 17-Aug-22Private Purchase 155,773$1.21$188,283.0011%
1.46M to 1.61M
30-Jun-22 4:15 PM
View: 
Steinman Lawrence
Director
Pasithea Therapeutics Corp. (KTTA) 29-Jun-22Grant 5,000$1.00$5,000.00< 1%
1.27M to 1.27M
30-Jun-22 4:15 PM
View: 
Steinman Lawrence
Director
Pasithea Therapeutics Corp. (KTTA) 28-Jun-22Grant 5,000$1.02$5,100.00< 1%
1.26M to 1.27M
27-Jun-22 4:15 PM
View: 
Steinman Lawrence
Director
Pasithea Therapeutics Corp. (KTTA) 27-Jun-22Grant 5,000$1.00$5,000.00< 1%
1.26M to 1.26M
23-Jun-22 4:31 PM
View: 
Steinman Lawrence
Director
Pasithea Therapeutics Corp. (KTTA) 23-Jun-22Grant 5,000$1.00$5,000.00< 1%
1.25M to 1.26M
23-Jun-22 5:10 PM
View: 
Marques Tiago
Chief Executive Officer
Director
Pasithea Therapeutics Corp. (KTTA) 23-Jun-22Grant 5,000$0.99$4,964.10< 1%
800.0K to 805.0K
22-Jun-22 4:30 PM
View: 
Steinman Lawrence
Director
Pasithea Therapeutics Corp. (KTTA) 21-Jun-22Grant 652,174----109%
600.0K to 1.25M
22-Dec-21 5:00 PM
View: 
Marques Tiago
Chief Executive Officer
Director
Pasithea Therapeutics Corp. (KTTA) 20-Dec-21Grant 200,000----33%
600.0K to 800.0K